A team of CRA transfer pricing consultants was engaged by a leading global medical device company to provide global transfer pricing advisory. CRA’s team has been instrumental in all parts of its transfer pricing analyses, including IP onshoring, planning, global documentation compliance, audit support, quarterly/year-end support as needed.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...